Receptor-targeted radiopharmaceuticals have shown promises in improvement of the specificity and sensitivity of nuclear medicine imaging and therapy procedures. The prostate specific membrane antigen (PSMA) is a transmembrane protein with significantly elevated expression in prostate cancer (PCa) cells compared to benign prostatic tissue. Several radiotracers have been used for molecular...
Background
In Thailand, PET/CT is a new technology of nuclear medicine with high efficacy for cancer diagnosing, measuring response to treatment, and guiding radiation therapy. With the advantages of PET/CT, physicians are able to accurately make treatment planning for each cancer patient toward the improved quality of life and longer survival. National Cyclotron and PET Centre was...
